Jesse Bonilla
Psychiatric/Mental Health · Santa Ana, CANPI 1689440711
Payments from drug & device makers
Across 96 payments — averaging $30.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$532
- Teva Pharmaceuticals USA, Inc.$316
- Vanda Pharmaceuticals Inc.$311
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$286
- Otsuka America Pharmaceutical, Inc.$187
- Lundbeck LLC$187
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,886100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $532 |
| Teva Pharmaceuticals USA, Inc. | 11 | $316 |
| Vanda Pharmaceuticals Inc. | 7 | $311 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $286 |
| Otsuka America Pharmaceutical, Inc. | 4 | $187 |
| Lundbeck LLC | 7 | $187 |
| Alkermes, Inc. | 4 | $185 |
| Ironshore Pharmaceuticals Inc. | 6 | $182 |
| Braeburn Inc. | 1 | $121 |
| Corium, LLC | 6 | $111 |
| Johnson & Johnson | 4 | $110 |
| Indivior Inc. | 4 | $98 |
| Axsome Therapeutics, Inc. | 3 | $90 |
| Noven Therapeutics, LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Biogen | 1 | $30 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$409
- UZEDY$125
- Fanapt$125
- BRIXADI$121
- ABILIFY MAINTENA$119
- ABILIFY ASIMTUFII$119
- VRAYLAR$113
How this compares
$2,886 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 17 | $248 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Santa Ana
- Janet SmithSanta Ana$18K
- Daniel MaiSanta Ana$13K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.